Literature DB >> 3008971

Susceptibility of gram-negative bacteria to the synergistic bactericidal action of serum and polymyxin B nonapeptide.

P Viljanen, H Käyhty, M Vaara, T Vaara.   

Abstract

Polymyxin B nonapeptide was able to sensitize Escherichia coli strains and strains of Salmonella typhimurium, Klebsiella spp., Enterobacter cloacae, Pseudomonas aeruginosa, and Haemophilus influenzae to the bactericidal action of fresh normal human serum. The degree of sensitization varied significantly within the strains. Strains of Proteus mirabilis, Neisseria gonorrhoeae, and N. meningitidis remained resistant.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3008971     DOI： 10.1139/m86-013

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN： 0008-4166            Impact factor:   2.419


  5 in total

Review 1.  Agents that increase the permeability of the outer membrane.

Authors:  M Vaara
Journal:  Microbiol Rev       Date:  1992-09

2.  Effects of polymyxin B nonapeptide on Aeromonas salmonicida.

Authors:  R N McCashion; W H Lynch
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

3.  A novel polymyxin derivative that lacks the fatty acid tail and carries only three positive charges has strong synergism with agents excluded by the intact outer membrane.

Authors:  Martti Vaara; Osmo Siikanen; Juha Apajalahti; John Fox; Niels Frimodt-Møller; Hui He; Anima Poudyal; Jian Li; Roger L Nation; Timo Vaara
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

4.  Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices.

Authors:  Michael R Yeaman; Kimberly D Gank; Arnold S Bayer; Eric P Brass
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

5.  Beneficial influence of platelets on antibiotic efficacy in an in vitro model of Staphylococcus aureus-induced endocarditis.

Authors:  Renee-Claude Mercier; Robert M Dietz; Jory L Mazzola; Arnold S Bayer; Michael R Yeaman
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.